Начало › Плоскоклетъчен карцином на главата и шията › Илинойс › Chicago
Клинични проучвания за Плоскоклетъчен карцином на главата и шията в Chicago, IL
26 проучвания за Плоскоклетъчен карцином на главата и шията търсят участници в обекти в и около Chicago (в радиус от около 30 мили). Отворете проучването, за да видите кой може да участва и как да се свържете с екипа.
Официален текст на проучването (английски)
Търсите участници за проучване? Представяме го в началото на тази страница — $99 за 30 дни →
High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer
Набиране на участнициФаза 3
- Advocate Illinois Masonic Medical Center, Chicago
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Набиране на участнициФаза 1
- University of Chicago Hospital, Chicago
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
Набиране на участнициФаза 2/3
- Captain James A Lovell Federal Health Care Center-VA North Chicago (Site # 133), Chicago
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Набиране на участнициФаза 1
- Exelixis Clinical Site #26, Chicago
Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
Набиране на участнициФаза 3
- University of Chicago Comprehensive Cancer Center, Chicago
- Advocate Illinois Masonic Medical Center, Chicago
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
Набиране на участнициФаза 3
- Rush University Medical Center Rush University Cancer Center Chicago, Chicago
- The University of Chicago Medical Center (UCMC), Chicago
A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer
Набиране на участнициФаза 1/2
- The University of Chicago Medical Center (UCMC), Chicago
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
Набиране на участнициФаза 2
- Northwestern University, Chicago
- University of Illinois, Chicago
Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
Набиране на участнициФаза 2
- Northwestern University, Chicago
- John H Stroger Jr Hospital of Cook County, Chicago
- University of Illinois, Chicago
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Набиране на участнициФаза 1
- Northwestern University Feinberg School of Medicine, Chicago
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
Набиране на участнициФаза 2
- John H Stroger Jr Hospital of Cook County, Chicago
- University of Chicago Comprehensive Cancer Center, Chicago
- Advocate Illinois Masonic Medical Center, Chicago
A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
Набиране на участнициНаблюдателно проучване
- Northwestern University Feinberg School of Medicine, Chicago
A Study to Assess the Adverse Events, Change in Disease Activity, and How Oral ABBV-711 Tablets Move Through the Body as a Monotherapy and in Combination With Intravenously Infused Budigalimab (ABBV-181), in Adults With Advanced Squamous Tumors
Набиране на участнициФаза 1
- University of Chicago Medical Center /ID# 276638, Chicago
Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer
Набиране на участнициФаза 2/3
- Northwestern University, Chicago
- Rush MD Anderson Cancer Center, Chicago
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
Набиране на участнициФаза 2
- Northwestern University, Chicago
Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin
Набиране на участнициФаза 3
- Northwestern University, Chicago
SMP-3124LP in Adults With Advanced Solid Tumors
Набиране на участнициФаза 1/2
- Northwestern Medicine Cancer Center, Chicago
- The University of Chicago, Chicago
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Набиране на участнициФаза 1
- UChicago Medicine - River East, Chicago
- The University Of Chicago, Chicago
- University of Chicago Medical Center, Chicago
A Study to Investigate ALE.P02 as Monotherapy in Adult Patients With Selected CLDN1+ Solid Tumors
Набиране на участнициФаза 1/2
- The University of Chicago Medical Center - Oncology, Chicago
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
Набиране на участнициФаза 1
- University of Illinois Hospital and Health Sciences System /ID# 251750, Chicago
- University of Chicago Medical Center /ID# 276271, Chicago
A Study of Pembrolizumab in Combination With Chemotherapy for Head and Neck Cancer
Набиране на участнициФаза 2
- University of Chicago Comprehensive Cancer Center, Chicago
A Study Evaluating the Safety and Efficacy of PRV111, PRV211, and PRV131 in Subjects With Oral and Lung Cancers
Набиране на участнициФаза 2/3
- The University of Chicago, Chicago
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
Набиране на участнициФаза 3
- University of Illinois Cancer Center, Chicago
Dosing Study of Radiation Combined With Tislelizumab and Pamiparib in Patients With Previously Treated Head and Neck Cancer
Набиране на участнициФаза 1
- The University of Chicago, Chicago
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Набиране на участнициФаза 1
- The University of Chicago Comprehensive Cancer Center, Chicago
A Study of NX-1607 in Adults With Advanced Malignancies
Набиране на участнициФаза 1
- University of Chicago, Chicago
Проучвания за Плоскоклетъчен карцином на главата и шията в други градове
- Houston, TX47 проучвания
- Los Angeles, CA42 проучвания
- Boston, MA40 проучвания
- New York City, NY39 проучвания
- Nashville, TN39 проучвания
- St. Louis, MO28 проучвания
- Arlington, VA26 проучвания
- Philadelphia, PA26 проучвания
- Atlanta, GA24 проучвания
- San Antonio, TX22 проучвания
- New Haven, CT22 проучвания
- Pittsburgh, PA22 проучвания
Други проучвания в Chicago
- Рак на белия дроб с недребноклетъчен тип61 проучвания
- Рак на гърдата59 проучвания
- Рак (всички видове)51 проучвания
- Метастатичен рак45 проучвания
- Рак на простатата45 проучвания
- Рак на белия дроб41 проучвания
- Затлъстяване41 проучвания
- Рак на яйчниците36 проучвания
- Колоректален рак34 проучвания
- Инсульт34 проучвания
- Сърдечна недостатъчност31 проучвания
- Наднормено тегло29 проучвания
От ClinicalTrials.gov, данни към 6.10.2026 г.. Всяко проучване има свои критерии за участие; екипът на проучването определя кой може да се включи.